Back
West Pharmaceutical Services, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
21
WST
West Pharmaceutical Services, Inc.
Last Price:
$231.25
Seasonality Move:
6.06%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowWest Pharmaceutical Services, Inc. Stock Forecast
-
Over the next 52 weeks, West Pharmaceutical Services, Inc. has on average historically risen by 14.6% based on the past 53 years of stock performance.
-
West Pharmaceutical Services, Inc. has risen higher in 38 of those 53 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.7%
-
Is West Pharmaceutical Services, Inc. Stock Undervalued?The current West Pharmaceutical Services, Inc. [WST] share price is $232.65. The Score for WST is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
WST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will West Pharmaceutical Services, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, West Pharmaceutical Services, Inc. has on average historically risen by 14.6% based on the past 53 years of stock performance.
West Pharmaceutical Services, Inc. Stock Rating
Sell
21
West Pharmaceutical Services, Inc. (WST)
is a Sell
Is West Pharmaceutical Services, Inc. overpriced?
-
West Pharmaceutical Services, Inc. has risen higher in 38 of those 53 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.7%
West Pharmaceutical Services, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
westpharma.com
52-Week Data
52-Week High:
347.85
52-Week Low:
187.43
Prediction Charts
Market Cap:
16.5B
Price in USD:
232.65
Volume:
930.2K
Beta:
0.76
Technical Analysis
SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
-31.49%
Stock Predictions
-
Is West Pharmaceutical Services, Inc. stock public?Yes, West Pharmaceutical Services, Inc. is a publicly traded company.
-
What is the West Pharmaceutical Services, Inc. stock quote today?The West Pharmaceutical Services, Inc. stock price is 232.65 USD today.
-
How to buy West Pharmaceutical Services, Inc. stock online?You can buy West Pharmaceutical Services, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-12 | 277.99 | 272.91 | 278.87 | 267.82 |
| Jan-13 | 273.59 | 271.83 | 275.49 | 268.42 |
| Jan-14 | 272.92 | 274.98 | 278.58 | 270.56 |
| Jan-15 | 275.62 | 279.41 | 281.55 | 272.81 |
| Jan-16 | 279.26 | 259.79 | 279.39 | 259.39 |
| Jan-20 | 255.00 | 250.50 | 255.00 | 248.47 |
| Jan-21 | 251.68 | 255.16 | 255.80 | 244.70 |
| Jan-22 | 256.18 | 247.78 | 258.74 | 247.03 |
| Jan-23 | 246.00 | 236.66 | 246.13 | 232.06 |
| Jan-26 | 238.48 | 241.40 | 241.40 | 236.80 |
| Jan-27 | 238.89 | 240.53 | 243.91 | 238.32 |
| Jan-28 | 238.10 | 235.89 | 239.06 | 234.88 |
| Jan-29 | 234.44 | 232.65 | 234.49 | 227.57 |
| Jan-30 | 229.43 | 231.12 | 232.05 | 223.83 |
West Pharmaceutical Services, Inc. Earnings
West Pharmaceutical Services, Inc. Earnings Report: Per Share West Pharmaceutical Services, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
West Pharmaceutical Services, Inc. Forecast Revenue Growth
West Pharmaceutical Services, Inc. Stock Analysis: Historical quarterly revenues per share for West Pharmaceutical Services, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $1.04 per share.
* West Pharmaceutical Services, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.